MeiraGTx Holdings PLC at Chardan Genetic Medicines Conference (Virtual) Transcript
It's now my pleasure to introduce our next fireside chat guest. From MeiraGTx, we have Dr. Zandy Forbes, President and Chief Executive Officer. Thank you, Zandy, for joining us today.
Thank you for having me. I'm happy to be here.
So Zandy, maybe we can start off by you providing us with a couple minutes of introductory comments on Meira and as well perhaps comment on any recent business developments and upcoming catalysts that we should keep in mind.
Thank you. So Meira is a gene therapy company currently focused in AAV. We have six clinical programs, with two entering pivotal studies. We have four programs in rare eye diseases. Our rare eye disease franchise is partnered with Janssen and our lead program there is in RPGR. We have a deep
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
